HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rong Deng Selected Research

hirsutanol A

2/2013Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: hirsutanol A inhibits tumor growth through ROS production.
1/2012Hirsutanol A induces apoptosis and autophagy via reactive oxygen species accumulation in breast cancer MCF-7 cells.
7/2010A novel sesquiterpene Hirsutanol A induces autophagical cell death in human hepatocellular carcinoma cells by increasing reactive oxygen species.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rong Deng Research Topics

Disease

66Neoplasms (Cancer)
01/2022 - 02/2006
16Infections
02/2022 - 09/2013
15Breast Neoplasms (Breast Cancer)
04/2022 - 01/2012
10Carcinogenesis
01/2021 - 11/2008
8Nasopharyngeal Carcinoma
01/2019 - 06/2007
7Human Influenza (Influenza)
02/2022 - 01/2016
6Neoplasm Metastasis (Metastasis)
12/2021 - 08/2014
6Triple Negative Breast Neoplasms
11/2021 - 01/2015
5Hepatocellular Carcinoma (Hepatoma)
01/2021 - 07/2010
5Leukemia
01/2019 - 12/2005
4Carcinoma (Carcinomatosis)
01/2022 - 01/2018
4Prostatic Neoplasms (Prostate Cancer)
01/2021 - 08/2014
4Cytomegalovirus Infections (Inclusion Disease)
01/2018 - 04/2014
3Adenocarcinoma of Lung
02/2022 - 12/2021
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 01/2018
3Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2018
3Body Weight (Weight, Body)
01/2021 - 01/2011
3Melanoma (Melanoma, Malignant)
11/2020 - 01/2018
3Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 09/2017
3Colonic Neoplasms (Colon Cancer)
01/2018 - 01/2012
3Osteosarcoma (Osteogenic Sarcoma)
02/2008 - 07/2007
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
06/2007 - 11/2005
3Thrombocytopenia (Thrombopenia)
06/2007 - 11/2005
2Nausea
02/2022 - 01/2020
2Liver Neoplasms (Liver Cancer)
01/2021 - 01/2018
2COVID-19
12/2020 - 10/2020
2Chromosome Aberrations (Chromosome Abnormalities)
01/2020 - 12/2019
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020 - 12/2019
2Adenocarcinoma
09/2019 - 10/2009
2Chronic Hepatitis B
01/2019 - 05/2018
2Fibrosis (Cirrhosis)
10/2018 - 05/2018
2Liver Diseases (Liver Disease)
10/2018 - 05/2018
2Viremia
01/2018 - 01/2017
2Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
01/2018 - 10/2009
2Autoimmune Diseases (Autoimmune Disease)
09/2015 - 11/2005

Drug/Important Bio-Agent (IBA)

13Monoclonal AntibodiesIBA
02/2022 - 03/2007
12Proteins (Proteins, Gene)FDA Link
10/2021 - 02/2006
8MicroRNAs (MicroRNA)IBA
01/2022 - 07/2015
8Phosphotransferases (Kinase)IBA
12/2021 - 04/2009
8Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2011
7gedivumabIBA
02/2022 - 01/2016
5Hemagglutinins (Hemagglutinin)IBA
02/2022 - 01/2016
5CytokinesIBA
10/2021 - 09/2015
5Immunoglobulins (Immunoglobulin)IBA
01/2021 - 03/2007
5Long Noncoding RNAIBA
01/2021 - 08/2014
5Pharmaceutical PreparationsIBA
01/2019 - 12/2005
5GoldIBA
01/2019 - 01/2017
5DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2012
4Beclin-1IBA
12/2021 - 11/2008
4LigandsIBA
10/2021 - 10/2009
4Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 07/2010
4Biological ProductsIBA
12/2020 - 01/2017
4AntibodiesIBA
12/2020 - 11/2005
4RG7667IBA
11/2018 - 08/2015
4AgarIBA
01/2018 - 10/2017
4Small Interfering RNA (siRNA)IBA
11/2013 - 02/2006
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2021 - 08/2012
3Histone DemethylasesIBA
02/2021 - 12/2017
3IronIBA
01/2021 - 07/2014
3Immune Checkpoint InhibitorsIBA
11/2020 - 01/2016
3Rituximab (Mabthera)FDA Link
01/2020 - 07/2013
3CateninsIBA
09/2019 - 11/2013
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 11/2007
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2015 - 08/2012
3TOR Serine-Threonine KinasesIBA
03/2015 - 08/2012
3hirsutanol AIBA
02/2013 - 07/2010
3rhabdastrellic acid AIBA
08/2010 - 08/2007
3Inosine Triphosphate (ITP)IBA
06/2007 - 11/2005
2pertuzumabIBA
04/2022 - 01/2021
2Trastuzumab (Herceptin)FDA Link
04/2022 - 01/2021
2Complement System Proteins (Complement)IBA
01/2022 - 09/2021
2ErbB Receptors (EGF Receptor)IBA
01/2022 - 12/2018
2atezolizumabIBA
11/2021 - 01/2016
2Autophagy-Related Protein-1 HomologIBA
10/2021 - 08/2011
2Glucose (Dextrose)FDA LinkGeneric
07/2021 - 03/2018
2Histones (Histone)IBA
01/2021 - 12/2017
2LipidsIBA
01/2021 - 03/2007
2ChromatinIBA
01/2021 - 12/2017
2PTEN Phosphohydrolase (PTEN Phosphatase)IBA
01/2021 - 01/2015
2B7-H1 AntigenIBA
01/2021 - 11/2020
2AlbuminsIBA
01/2021 - 11/2018
2Polo-Like Kinase 1IBA
12/2020 - 01/2019
2human ERBB2 proteinIBA
12/2020 - 11/2019
2Antiviral Agents (Antivirals)IBA
12/2020 - 10/2018
2Oseltamivir (Tamiflu)FDA Link
11/2020 - 01/2020
2venetoclaxIBA
01/2020 - 12/2019
2AGRO 100IBA
01/2019 - 01/2018
2Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 01/2017
2AntigensIBA
01/2019 - 07/2013
2Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 09/2013
2Tyrosine Kinase InhibitorsIBA
12/2018 - 07/2015
2Immunoglobulin G (IgG)IBA
01/2017 - 01/2016
2Tumor Suppressor Protein p14ARF (p14ARF)IBA
10/2016 - 07/2007
2EpitopesIBA
01/2016 - 09/2015
2N- (1- amino- 3- (2,4- dichlorophenyl)propan- 2- yl)- 2- (2- (methylamino)pyrimidin- 4- yl)thiazole- 5- carboxamideIBA
03/2015 - 08/2012

Therapy/Procedure

22Therapeutics
11/2021 - 03/2007
6Drug Therapy (Chemotherapy)
11/2021 - 07/2007
5Immunotherapy
01/2022 - 03/2007
3Length of Stay
02/2022 - 12/2021
2Subcutaneous Injections
04/2022 - 01/2021